Ambu on EU bronchoscope approval: Makes us the most wide-ranging and dominant player on the market
Wednesday's CE mark authorization for Ambu's latest bronchoscope and attached sampling system will have a positive effect on the company's total endoscopy sales, and the green light itself shows that they are the most innovative player, the firm says.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
Competition has been heating up on the market for pulmonary endoscopes, also called bronchoscopes, where Ambu's product Ascope has been very successful.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu gets EU approval for bronchoscope
For subscribers
Ambu changes stance, mandates vaccines for US workers
For subscribers
